Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
about
Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?Childhood acute myeloid leukaemiaAdvancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% curePhase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.Definition of cure in childhood acute myeloid leukemia.The cladribine conundrum: deciphering the drug's mechanism of action.Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.Recent advancements of flow cytometry: new applications in hematology and oncology.Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.Effect of body mass index on the outcome of children with acute myeloid leukemia.G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.Treatment outcome in older patients with childhood acute myeloid leukemiaPROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables.RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.Novel therapies for children with acute myeloid leukaemia.Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.Management of isolated recurrence of extramedullary myeloid tumor at a single site.Deoxycytidine-kinase knockdown as a novel myeloprotective strategy in the context of fludarabine, cytarabine or cladribine therapy.Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
P2860
Q26860830-3903EBBD-4922-4117-A0AF-DB8C1ABBD5EFQ27005960-172EC647-6F6B-4FC1-9253-9E6F91CB7B95Q27027799-BCA80FD9-DDC6-4C8F-A5A3-DAFE4B96BA24Q33400806-1346398E-C6F5-4776-AC69-25FB15B0657FQ33779342-CEE95B35-E656-4F10-8C71-369569BC1538Q34809196-63C987C0-E80A-4022-9D1E-FB0E46A32260Q35016421-01E39FBD-72AB-48AF-8BBE-36BDE781A383Q35048344-937B533E-1AA4-4D25-B5E7-BEEF9C33B239Q35059549-8B45A5B8-33E0-4EDC-8089-D1AAAE4F5405Q35114704-E9528B6A-7191-4F2E-9398-9C4C08080F22Q35209900-0B3E2645-1C8A-444B-9E67-734FCF698754Q35265653-C023D528-3BAB-4CD0-BA90-708439361D9CQ36210124-D719BC22-72EB-48E4-9302-9EF7619D0E84Q36478979-CDB23B27-C994-4FCF-878D-A184F1909D94Q36570763-85448D58-110D-444E-90AB-3C4A14763A10Q37295110-D7F212F8-266F-43E7-B10A-38BC2B55DF24Q37387162-C648A168-B46B-4680-A353-5BF104F08064Q37579563-EE9D0F6E-1D5F-401D-9879-5E98DA6B12F5Q38096798-500609D4-3E1E-4717-9CD0-332712719C2BQ38757036-695B2B44-AF2F-497F-B626-E45E0579FAD8Q42108594-F367EE36-2AE1-4327-9387-2DDDAFE0AA2AQ45875395-50159D24-85D3-4411-A5CE-B57DBE9EF2A2Q47137275-DF616A9C-28F3-4774-81FF-A537E0AC728E
P2860
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combination of cladribine and ...... lts of the St Jude AML97 trial
@en
Combination of cladribine and ...... ts of the St Jude AML97 trial.
@nl
type
label
Combination of cladribine and ...... lts of the St Jude AML97 trial
@en
Combination of cladribine and ...... ts of the St Jude AML97 trial.
@nl
prefLabel
Combination of cladribine and ...... lts of the St Jude AML97 trial
@en
Combination of cladribine and ...... ts of the St Jude AML97 trial.
@nl
P2093
P2860
P356
P1433
P1476
Combination of cladribine and ...... lts of the St Jude AML97 trial
@en
P2093
B I Razzouk
J R Downing
R C Ribeiro
S C Raimondi
V V Gandhi
P2860
P2888
P304
P356
10.1038/LEU.2009.30
P577
2009-02-26T00:00:00Z